Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1994-04-19
1996-04-30
Chan, Nicky
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
514572, 560 9, 560 53, 560 57, 560 61, 560 62, 560 63, 562426, 562464, 562468, 562471, 562472, A61K 31215, A61K 3139, C07C 69612, C07C 5911
Patent
active
055125956
ABSTRACT:
New substituted phenoxyisobutyric acids and esters that can be used as medicaments and correspond to the formula: ##STR1## wherein X, A, R, R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, R.sub.6, R.sub.7 and Z are as defined in the description.
Those compounds and their physiologically tolerable salts can be used therapeutically.
REFERENCES:
Role of Oxidized Low Density Lipoprotein in Atherogenesis by Witztum, et al., J. Clin. Invest. vol. 88, pp. 1785-1792 (Dec. 1991).
Malondialdehyde-modified Low Density Lipoproteins in Patients with Atherosclerotic Disease by Holvoet, et al., J. Clin. Invest., vol. 95, pp. 2611-2619 (Jun. 1995).
Increased Susceptibility to Lipid Oxidation of Low-Density Lipoproteins and Erythrocyte Membranes From Diabetic Patients by Rabini, et al., Metabolism, vol. 43, No. 12, pp. 1470-1474 (Dec. 1994).
Serum Antioxidants and Myocardial Infarction by Street, et al., American Heart Association, Inc., pp. 1154-1161 (1994).
Antioxidant vitamins and coronary heart disease risk by Clifton, Division of Human Nutrition, Commonwealth Scientific and Industrial Research Organisation, Adelaide, Australia, Current Opinion in Lipidology 1995, 6:20-24.
Effect of Alpha-tocopherol on Restenosis after Angioplasty in a Model of Experimental Atherosclerosis by Lafont, et al., J. Clin. Invest., vol. 95, pp. 1018-1025 (Mar. 1995).
Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis by Palinski, et al., Proc. Natl. Acad. Sci. USA, vol. 92, pp. 821-825 (Jan. 1995) Medical Sciences.
Breugnot Christine
Guillonneau Claude
Lenaers Albert
Regnier Gilbert
Vilaine Jean-Paul
Adir et Compagnie
Chan Nicky
Hueschen Gordon W.
LandOfFree
Substituted phenoxyisobutyric acids and esters does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted phenoxyisobutyric acids and esters, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted phenoxyisobutyric acids and esters will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-629122